(1) Poll results of the 2026 first extraordinary general meeting held on October 9, 2026; (2) resignation of independent non-executive director; (3) appointment of independent non-executive director; and (4) change of composition of board committees
Filed with HKEX · Stock code 2185 · · 4 pages · English
Summary by 6ix AI
The meeting included the resignation of an independent non-executive director and the appointment of a new independent non-executive director. Additionally, there were changes to the composition of the board committees following these changes.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Shanghai Bio-Heart Biological Technology Co., Ltd. on 6ix
Earlier from Shanghai Bio-Heart Biological Technology
- Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026
- 2026 Interim report
- Proxy form for use at the 2026 first extraordinary general meeting to be held on October 9, 2026
- Proposed appointment of independent non-executive director; and (2) notice of 2026 first extraordinary general meeting
- Notice of 2026 first extraordinary general meeting
Later from Shanghai Bio-Heart Biological Technology
- List of directors and their roles and functions
- Adoption of the china accounting standards for business enterprises for the preparation of financial reports on a uniform basis and proposed change of auditor
Follow Shanghai Bio-Heart Biological Technology into a list and get an email when it puts out news.
Follow Shanghai Bio-Heart Biological Technology